Evidence map›Paper›PMID 27165704›Full record

ReviewEuropean biophysics journal : EBJ2016

K

Benjamin Stegen, Lukas Klumpp, Milan Misovic, Lena Edalat, Marita Eckert, Dominik Klumpp, Peter Ruth, Stephan M Huber

Abstract readReview
PubMed Publisher
In one paragraph

Review in European biophysics journal : EBJ, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. BKJournal of neuro-oncology · 2026
    Article
  2. KCa3.1 mediates radioresistance of silver nanoparticles in human glioblastoma cells.Pflugers Archiv : European journal of physiology · 2026
    Article
  3. Article
  4. Ion Channels in Gliomas-From Molecular Basis to Treatment.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Ion Transport and Radioresistance.Reviews of physiology, biochemistry and pharmacology · 2022
    Review
  10. Review
  11. Article
  12. Methylation geneOncology reports · 2021
    Article
  13. Potassium Channels in Cancer.Handbook of experimental pharmacology · 2021
    Article
  14. Review
  15. hERG KFrontiers in pharmacology · 2020
    Article
  16. KCancers · 2019
    Article
  17. Article
  18. Review
  19. Review
  20. Role of KCa3.1 Channels in Modulating CaInternational journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benjamin StegenDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Lukas KlumppDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Milan MisovicDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Lena EdalatDepartment of Pharmacology, Toxicology and Clinical Pharmacy, University of Tübingen, Tübingen, Germany.
Marita EckertDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Dominik KlumppDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany.
Peter RuthDepartment of Pharmacology, Toxicology and Clinical Pharmacy, University of Tübingen, Tübingen, Germany.
Stephan M HuberDepartment of Radiation Oncology, University of Tübingen, Tübingen, Germany. stephan.huber@uni-tuebingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

K

Indexed as

AnimalsHumansNeoplasmsPotassium ChannelsSignal TransductionPotassium ChannelsCa2+ signalosomeElectrosignalingFractionated radiation therapyFura-2 Ca2+ imagingOncochannelsPatch-clamp recording

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.